Gastrointestinal injury associated with NSAID use: a case study and review of risk factors and preventative strategies

References

• WilcoxCMCryerBTriadafilopoulosGPatterns of use and public perception of over-the-counter pain relievers: focus on nonsteroidal antiinflammatory drugsJ Rheumatol200532112218222416265706
   PubMed Web of Science ®Google Scholar
• ZhouYBoudreauDMFreedmanANTrends in the use of aspirin and nonsteroidal anti-inflammatory drugs in the general U.S. populationPharmacoepidemiol Drug Saf2014231435023723142
   PubMed Web of Science ®Google Scholar
• GoldsteinJLLefkowithJBPublic misunderstanding of nonsteroidal antiinflammatory drug (NSAID)-mediated gastrointestinal (GI) toxicity: a serious potential health threatGastroenterology1998114A136
   Web of Science ®Google Scholar
• CaponeMLTacconelliSRodriguezLGPatrignaniPNSAIDs and cardiovascular disease: transducing human pharmacology results into clinical read-outs in the general populationPharmacol Rep201062353053520631418
   PubMed Web of Science ®Google Scholar
• García RodríguezLATacconelliSPatrignaniPRole of dose potency in the prediction of risk of myocardial infarction associated with nonsteroidal anti-inflammatory drugs in the general populationJ Am Coll Cardiol200852201628163618992652
   PubMed Web of Science ®Google Scholar
• HarirforooshSAsgharWJamaliFAdverse effects of nonsteroidal antiinflammatory drugs: an update of gastrointestinal, cardiovascular and renal complicationsJ Pharm Pharm Sci201316582184724393558
   PubMed Web of Science ®Google Scholar
• ChoudhuryDAhmedZDrug-associated renal dysfunction and injuryNat Clin Pract Nephrol200622809116932399
   PubMedGoogle Scholar
• Public Health Advisory – FDA Announces Important Changes and Additional Warnings for COX-2 Selective and Non-Selective Non-Steroidal AntiInflammatory Drugs (NSAIDs) [webpage on the Internet]Silver Spring, MDUS Food and Drug Administration2005 [updated August 16, 2013; accessed October 10, 2014]. Available from: http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm150314.htmAccessed October 10, 2014
   Google Scholar
• AntmanEMBennettJSDaughertyAFurbergCRobertsHTaubertKAAmerican Heart AssociationUse of nonsteroidal antiinflammatory drugs: an update for clinicians: a scientific statement from the American Heart AssociationCirculation2007115121634164217325246
   PubMed Web of Science ®Google Scholar
• ButtJHBarthelJSMooreRAClinical spectrum of the upper gastrointestinal effects of nonsteroidal anti-inflammatory drugs. Natural history, symptomatology, and significanceAm J Med1988842A5143279767
   PubMedGoogle Scholar
• FriesJToward an understanding of NSAID-related adverse events: the contribution of longitudinal dataScand J Rheumatol Suppl1996102388628980
   PubMedGoogle Scholar
• de JagerCPWeverPCGemenEFProton pump inhibitor therapy predisposes to community-acquired Streptococcus pneumoniae pneumoniaAliment Pharmacol Ther2012361094194923034135
   PubMed Web of Science ®Google Scholar
• SinghGGastrointestinal complications of prescription and over-the-counter nonsteroidal anti-inflammatory drugs: a view from the ARAMIS database. Arthritis, Rheumatism, and Aging Medical Information SystemAm J Ther20007211512111319579
   PubMedGoogle Scholar
• SilversteinFEGrahamDYSeniorJRMisoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs. A randomized, double-blind, placebo-controlled trialAnn Intern Med199512342412497611589
   PubMed Web of Science ®Google Scholar
• BombardierCLaineLReicinAVIGOR Study GroupComparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study GroupN Engl J Med2000343211520152811087881
   PubMed Web of Science ®Google Scholar
• SilversteinFEFaichGGoldsteinJLGastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety StudyJAMA2000284101247125510979111
   PubMed Web of Science ®Google Scholar
• LaineLBombardierCHawkeyCJStratifying the risk of NSAID-related upper gastrointestinal clinical events: results of a double-blind outcomes study in patients with rheumatoid arthritisGastroenterology200212341006101212360461
   PubMed Web of Science ®Google Scholar
• CryerBLiCSimonLSSinghGStillmanMJBergerMFGI-REASONS: a novel 6-month, prospective, randomized, open-label, blinded endpoint (PROBE) trialAm J Gastroenterol2013108339240023399552
   PubMed Web of Science ®Google Scholar
• García RodríguezLAJickHRisk of upper gastrointestinal bleeding and perforation associated with individual non-steroidal anti-inflammatory drugsLancet199434389007697727907735
   PubMed Web of Science ®Google Scholar
• WarnerTDGiulianoFVojnovicIBukasaAMitchellJAVaneJRNonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysisProc Natl Acad Sci U S A199996137563756810377455
   PubMed Web of Science ®Google Scholar
• WallaceJLProstaglandins, NSAIDs, and gastric mucosal protection: why doesn’t the stomach digest itself?Physiol Rev20088841547156518923189
   PubMed Web of Science ®Google Scholar
• LanasAScarpignatoCMicrobial flora in NSAID-induced intestinal damage: a role for antibiotics?Digestion200673Suppl 113615016498262
   PubMed Web of Science ®Google Scholar
• BrunoATacconelliSPatrignaniPVariability in the response to non-steroidal anti-inflammatory drugs: mechanisms and perspectivesBasic Clin Pharmacol Toxicol20141141566323953622
   PubMed Web of Science ®Google Scholar
• Celebrex^® (celecoxib) [package insert]New York, NYPfizer2008
   Google Scholar
• O’RiordanMFDA Advisory Panel Votes Against CV Safety Claim for Naproxen [webpage on the Internet]New York, NYMedscape2014 Available from: http://www.medscape.com/viewarticle/820470Accessed May 14, 2014
   Google Scholar
• SahinIHHassanMMGarrettCRImpact of non-steroidal anti-inflammatory drugs on gastrointestinal cancers: current state-of-the scienceCancer Lett2014345224925724021750
   PubMed Web of Science ®Google Scholar
• LindbladMLagergrenJGarcía RodríguezLANonsteroidal anti-inflammatory drugs and risk of esophageal and gastric cancerCancer Epidemiol Biomarkers Prev200514244445015734971
   PubMed Web of Science ®Google Scholar
• SørensenHTFriisSNørgårdBRisk of cancer in a large cohort of nonaspirin NSAID users: a population-based studyBr J Cancer200388111687169212771981
   PubMed Web of Science ®Google Scholar
• WongBCZhangLMaJLEffects of selective COX-2 inhibitor and Helicobacter pylori eradication on precancerous gastric lesionsGut201261681281821917649
   PubMed Web of Science ®Google Scholar
• SostresCGargalloCJLanasANonsteroidal anti-inflammatory drugs and upper and lower gastrointestinal mucosal damageArthritis Res Ther201315Suppl 3S324267289
   PubMed Web of Science ®Google Scholar
• ArmstrongCPBlowerALNon-steroidal anti-inflammatory drugs and life threatening complications of peptic ulcerationGut19872855275323596334
   PubMed Web of Science ®Google Scholar
• SinghGRameyDRMorfeldDShiHHatoumHTFriesJFGastrointestinal tract complications of nonsteroidal anti-inflammatory drug treatment in rheumatoid arthritis. A prospective observational cohort studyArch Intern Med199615614153015368687261
   PubMedGoogle Scholar
• StraubeSTramèrMRMooreRADerrySMcQuayHJMortality with upper gastrointestinal bleeding and perforation: effects of time and NSAID useBMC Gastroenterol200994119500343
   PubMed Web of Science ®Google Scholar
• SivaRAl ZubaidiGMasoudAKNiharMPredictive factors for failure of endoscopic management therapy in peptic ulcer bleedingSaudi J Gastroenterol200281172119861786
   PubMedGoogle Scholar
• LaiKCChuKMHuiWMCelecoxib compared with lansoprazole and naproxen to prevent gastrointestinal ulcer complicationsAm J Med2005118111271127816271912
   PubMed Web of Science ®Google Scholar
• BarkunANBardouMKuipersEJInternational Consensus Upper Gastrointestinal Bleeding Conference GroupInternational consensus recommendations on the management of patients with nonvariceal upper gastrointestinal bleedingAnn Intern Med2010152210111320083829
   PubMed Web of Science ®Google Scholar
• LangmanMJMorganLWorrallAUse of anti-inflammatory drugs by patients admitted with small or large bowel perforations and haemorrhageBr Med J (Clin Res Ed)19852906465347349
   Web of Science ®Google Scholar
• BjorkmanDNonsteroidal anti-inflammatory drug-associated toxicity of the liver, lower gastrointestinal tract, and esophagusAm J Med19981055A17S21S9855171
   PubMedGoogle Scholar
• LaineLConnorsLGReicinASerious lower gastrointestinal clinical events with nonselective NSAID or coxib useGastroenterology2003124228829212557133
   PubMed Web of Science ®Google Scholar
• LanasAPerez-AisaMAFeuFInvestigators of the Asociación Española de Gastroenterología (AEG)A nationwide study of mortality associated with hospital admission due to severe gastrointestinal events and those associated with nonsteroidal antiinflammatory drug useAm J Gastroenterol200510081685169316086703
   PubMed Web of Science ®Google Scholar
• ChanFKCryerBGoldsteinJLA novel composite endpoint to evaluate the gastrointestinal (GI) effects of nonsteroidal antiinflammatory drugs through the entire GI tractJ Rheumatol201037116717419884267
   PubMed Web of Science ®Google Scholar
• GoldsteinJLEisenGMLewisBGralnekIMZlotnickSFortJGInvestigatorsVideo capsule endoscopy to prospectively assess small bowel injury with celecoxib, naproxen plus omeprazole, and placeboClin Gastroenterol Hepatol20053213314115704047
   PubMed Web of Science ®Google Scholar
• MaidenLThjodleifssonBTheodorsAGonzalezJBjarnasonIA quantitative analysis of NSAID-induced small bowel pathology by capsule enteroscopyGastroenterology200512851172117815887101
   PubMed Web of Science ®Google Scholar
• ChanFKLanasAScheimanJBergerMFNguyenHGoldsteinJLCelecoxib versus omeprazole and diclofenac in patients with osteoarthritis and rheumatoid arthritis (CONDOR): a randomised trialLancet2010376973617317920638563
   PubMed Web of Science ®Google Scholar
• KellnerHLLiCEssexMNCelecoxib and diclofenac plus omeprazole are similarly effective in the treatment of arthritis in patients at high GI risk in the CONDOR TrialOpen Rheumatol J201379610024358067
   PubMedGoogle Scholar
• BowenBYuanYJamesCRashidFHuntRHTime course and pattern of blood loss with ibuprofen treatment in healthy subjectsClin Gastroenterol Hepatol20053111075108216271337
   PubMed Web of Science ®Google Scholar
• GoldsteinJLChanFKLanasAHaemoglobin decreases in NSAID users over time: an analysis of two large outcome trialsAliment Pharmacol Ther201134780881621810115
   PubMed Web of Science ®Google Scholar
• ConaghanPGDicksonJGrantRLGuideline Development GroupCare and management of osteoarthritis in adults: summary of NICE guidanceBMJ2008336764250250318310005
   PubMed Web of Science ®Google Scholar
• LanzaFLChanFKQuigleyEMPractice Parameters Committee of the American College of GastroenterologyGuidelines for prevention of NSAID-related ulcer complicationsAm J Gastroenterol2009104372873819240698
   PubMed Web of Science ®Google Scholar
• HochbergMCAltmanRDAprilKTAmerican College of RheumatologyAmerican College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and kneeArthritis Care Res (Hoboken)201264446547422563589
   PubMed Web of Science ®Google Scholar
• Van HeckenASchwartzJIDepréMComparative inhibitory activity of rofecoxib, meloxicam, diclofenac, ibuprofen, and naproxen on COX-2 versus COX-1 in healthy volunteersJ Clin Pharmacol200040101109112011028250
   PubMed Web of Science ®Google Scholar
• JankovicSMAleksicJRakovicSNonsteroidal antiinflammatory drugs and risk of gastrointestinal bleeding among patients on hemodialysisJ Nephrol200922450250719662606
   PubMed Web of Science ®Google Scholar
• FriesJFWilliamsCABlochDAMichelBANonsteroidal anti-inflammatory drug-associated gastropathy: incidence and risk factor modelsAm J Med19919132132221892140
   PubMed Web of Science ®Google Scholar
• Hernández-DíazSRodríguezLAAssociation between nonsteroidal anti-inflammatory drugs and upper gastrointestinal tract bleeding/perforation: an overview of epidemiologic studies published in the 1990sArch Intern Med2000160142093209910904451
   PubMedGoogle Scholar
• Garcia RodríguezLAHernández-DíazSThe risk of upper gastrointestinal complications associated with nonsteroidal anti-inflammatory drugs, glucocorticoids, acetaminophen, and combinations of these agentsArthritis Res2001329810111178116
   PubMedGoogle Scholar
• ShorrRIRayWADaughertyJRGriffinMRConcurrent use of nonsteroidal anti-inflammatory drugs and oral anticoagulants places elderly persons at high risk for hemorrhagic peptic ulcer diseaseArch Intern Med199315314166516708333804
   PubMedGoogle Scholar
• LeontiadisGISreedharanADorwardSSystematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleedingHealth Technol Assess20071151iiiiv116418021578
   PubMed Web of Science ®Google Scholar
• JohnsenSPSørensenHTMellemkjoerLHospitalisation for upper gastrointestinal bleeding associated with use of oral anticoagulantsThromb Haemost200186256356811522004
   PubMed Web of Science ®Google Scholar
• LanasAGarcía-RodríguezLAArroyoMTInvestigators of the Asociación Española de Gastroenterología (AEG)Effect of anti-secretory drugs and nitrates on the risk of ulcer bleeding associated with nonsteroidal anti-inflammatory drugs, antiplatelet agents, and anticoagulantsAm J Gastroenterol2007102350751517338735
   PubMed Web of Science ®Google Scholar
• MascleeGMValkhoffVEvan SoestEMCyclo-oxygenase-2 inhibitors or nonselective NSAIDs plus gastroprotective agents: what to prescribe in daily clinical practice?Aliment Pharmacol Ther201338217818923710837
   PubMed Web of Science ®Google Scholar
• de AbajoFJRodríguezLAMonteroDAssociation between selective serotonin reuptake inhibitors and upper gastrointestinal bleeding: population based case-control studyBMJ199931972171106110910531103
   PubMed Web of Science ®Google Scholar
• de JongJCvan den BergPBTobiHde Jong-van den BergLTCombined use of SSRIs and NSAIDs increases the risk of gastrointestinal adverse effectsBr J Clin Pharmacol200355659159512814454
   PubMed Web of Science ®Google Scholar
• LokeYKTrivediANSinghSMeta-analysis: gastrointestinal bleeding due to interaction between selective serotonin uptake inhibitors and non-steroidal anti-inflammatory drugsAliment Pharmacol Ther2008271314017919277
   PubMed Web of Science ®Google Scholar
• Helin-SalmivaaraAHuttunenTGrönroosJMKlaukkaTHuupponenRRisk of serious upper gastrointestinal events with concurrent use of NSAIDs and SSRIs: a case-control study in the general populationEur J Clin Pharmacol200763440340817347805
   PubMed Web of Science ®Google Scholar
• AbrahamNSEl-SeragHBJohnsonMLNational adherence to evidence-based guidelines for the prescription of nonsteroidal anti-inflammatory drugsGastroenterology200512941171117816230071
   PubMed Web of Science ®Google Scholar
• LanasAGarcia-TellGArmadaBOteo-AlvaroAPrescription patterns and appropriateness of NSAID therapy according to gastrointestinal risk and cardiovascular history in patients with diagnoses of osteoarthritisBMC Med201193821489310
   PubMed Web of Science ®Google Scholar
• SmalleyWSteinCMArbogastPGEisenGRayWAGriffinMUnderutilization of gastroprotective measures in patients receiving nonsteroidal antiinflammatory drugsArthritis Rheum20024682195220012209525
   PubMed Web of Science ®Google Scholar
• SturkenboomMCBurkeTATangelderMJDielemanJPWaltonSGoldsteinJLAdherence to proton pump inhibitors or H2-receptor antagonists during the use of non-steroidal anti-inflammatory drugsAliment Pharmacol Ther20031811–121137114714653834
   PubMed Web of Science ®Google Scholar
• GoldsteinJLHowardKBWaltonSMMcLaughlinTPKruzikasDTImpact of adherence to concomitant gastroprotective therapy on non-steroidal-related gastroduodenal ulcer complicationsClin Gastroenterol Hepatol20064111337134517088110
   PubMed Web of Science ®Google Scholar
• EomCSJeonCYLimJWChoEGParkSMLeeKSUse of acid-suppressive drugs and risk of pneumonia: a systematic review and meta-analysisCMAJ2011183331031921173070
   PubMed Web of Science ®Google Scholar
• HessMWHoenderopJGBindelsRJDrenthJPSystematic review: hypomagnesaemia induced by proton pump inhibitionAliment Pharmacol Ther201236540541322762246
   PubMed Web of Science ®Google Scholar
• YuEWBauerSRBainPABauerDCProton pump inhibitors and risk of fractures: a meta-analysis of 11 international studiesAm J Med2011124651952621605729
   PubMed Web of Science ®Google Scholar
• JanarthananSDitahIAdlerDGEhrinpreisMNClostridium difficile-associated diarrhea and proton pump inhibitor therapy: a meta-analysisAm J Gastroenterol201210771001101022710578
   PubMed Web of Science ®Google Scholar
• RostomADubeCWellsGPrevention of NSAID-induced gastroduodenal ulcersCochrane Database Syst Rev20024CD00229612519573
   PubMedGoogle Scholar
• TangOSGemzell-DanielssonKHoPCMisoprostol: pharmacokinetic profiles, effects on the uterus and side-effectsInt J Gynaecol Obstet200799Suppl 2S160S16717963768
   PubMed Web of Science ®Google Scholar
• LaineLKivitzAJBelloAEGrahnAYSchiffMHTahaASDouble-blind randomized trials of single-tablet ibuprofen/high-dose famotidine vs. ibuprofen alone for reduction of gastric and duodenal ulcersAm J Gastroenterol2012107337938622186979
   PubMed Web of Science ®Google Scholar
• McGettiganPHenryDCardiovascular risk with non-steroidal anti-inflammatory drugs: systematic review of population-based controlled observational studiesPLoS Med201189e100109821980265
   PubMed Web of Science ®Google Scholar
• MasseyTDerrySMooreRAMcQuayHJTopical NSAIDs for acute pain in adultsCochrane Database Syst Rev20106CD00740220556778
   PubMed Web of Science ®Google Scholar
• LissyMScallionRStiffDDMooreKPharmacokinetic comparison of an oral diclofenac potassium liquid-filled soft gelatin capsule with a diclofenac potassium tabletExpert Opin Pharmacother201011570170820187842
   PubMed Web of Science ®Google Scholar
• GibofskyASilbersteinSArgoffCDanielsSJensenSYoungCLLower-dose diclofenac submicron particle capsules provide early and sustained acute patient pain relief in a phase 3 studyPostgrad Med2013125513013824113671
   PubMed Web of Science ®Google Scholar
• AltmanRDanielsSYoungCLIndomethacin submicron particle capsules provide effective pain relief in patients with acute pain: a phase 3 studyPhys Sportsmed201341471524231592
   PubMed Web of Science ®Google Scholar
• RostomAWellsGTugwellPWelchVDubéCMcGowanJThe prevention of chronic NSAID induced upper gastrointestinal toxicity: a Cochrane collaboration metaanalysis of randomized controlled trialsJ Rheumatol20002792203221410990235
   PubMed Web of Science ®Google Scholar
• BocanegraTSWeaverALTindallEADiclofenac/misoprostol compared with diclofenac in the treatment of osteoarthritis of the knee or hip: a randomized, placebo controlled trial. Arthrotec Osteoarthritis Study GroupJ Rheumatol1998258160216119712107
   PubMed Web of Science ®Google Scholar
• AlMJManiadakisNGrijseelsEWJanssenMCosts and effects of various analgesic treatments for patients with rheumatoid arthritis and osteoarthritis in the NetherlandsValue Health200811458959918194404
   PubMed Web of Science ®Google Scholar
• SturkenboomMCBurkeTADielemanJPTangelderMJLeeFGoldsteinJLUnderutilization of preventive strategies in patients receiving NSAIDsRheumatology (Oxford)200342Suppl 3iii233114585915
   PubMed Web of Science ®Google Scholar
• LanasAPolo-TomásMRoncalesPGonzalezMAZapardielJPrescription of and adherence to non-steroidal anti-inflammatory drugs and gastroprotective agents in at-risk gastrointestinal patientsAm J Gastroenterol2012107570771422334248
   PubMed Web of Science ®Google Scholar
• ParkSHChoCSLeeOYComparison of prevention of NSAID-induced gastrointestinal complications by rebamipide and misoprostol: a randomized, multicenter, controlled trial-STORM STUDYJ Clin Biochem Nutr200740214815518188417
   PubMed Web of Science ®Google Scholar
• RostomAMuirKDubéCGastrointestinal safety of cyclooxygenase-2 inhibitors: a Cochrane Collaboration systematic reviewClin Gastroenterol Hepatol200757818828828. e1e517556027
   PubMed Web of Science ®Google Scholar
• US Food and Drug AdministrationFDA issues public health advisory on Vioxx as its manufacturer voluntarily withdraws the product [press release]Silver Spring, MDUS Food and Drug Administration2004 [September 30] [updated April 2, 2013; cited October 10, 2014]. Available from: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2004/ucm108361.htmAccessed October 2, 2014
   Google Scholar
• GreenbergJDFisherMCKremerJCORRONA InvestigatorsThe COX-2 inhibitor market withdrawals and prescribing patterns by rheumatologists in patients with gastrointestinal and cardiovascular riskClin Exp Rheumatol200927339540119604430
   PubMed Web of Science ®Google Scholar
• CaldwellJRRothSHA double blind study comparing the efficacy and safety of enteric coated naproxen to naproxen in the management of NSAID intolerant patients with rheumatoid arthritis and osteoarthritis. Naproxen EC Study GroupJ Rheumatol19942146896958035394
   PubMed Web of Science ®Google Scholar
• Le LoëtXDreiserRLLe GrosVFebvreNTherapeutic equivalence of diclofenac sustained-released 75 mg tablets and diclofenac enteric-coated 50 mg tablets in the treatment of painful osteoarthritisInt J Clin Pract19975163893939489070
   PubMed Web of Science ®Google Scholar
• KhongTKDowningMEEllisRPatchettITraynerJMillerAJThe efficacy and tolerability of enteric and non-enteric coated naproxen tablets: a double-blind study in patients with osteoarthritisCurr Med Res Opin19911285405461764957
   PubMed Web of Science ®Google Scholar
• BellamyNBeaulieuABombardierCEfficacy and tolerability of enteric-coated naproxen in the treatment of osteoarthritis and rheumatoid arthritis: a double-blind comparison with standard naproxen followed by an open-label trialCurr Med Res Opin199212106406511633722
   PubMed Web of Science ®Google Scholar
• DaviesNMSustained release and enteric coated NSAIDs: are they really GI safe?J Pharm Pharm Sci19992151410951657
   PubMed Web of Science ®Google Scholar
• RolfCEngströmBBeauchardCJacobsLDLe LibouxAIntra-articular absorption and distribution of ketoprofen after topical plaster application and oral intake in 100 patients undergoing knee arthroscopyRheumatology (Oxford)199938656456710402079
   PubMed Web of Science ®Google Scholar
• MartensMEfficacy and tolerability of a topical NSAID patch (local action transcutaneous flurbiprofen) and oral diclofenac in the treatment of soft-tissue rheumatismClin Rheumatol199716125319132322
   PubMed Web of Science ®Google Scholar
• TugwellPSWellsGAShainhouseJZEquivalence study of a topical diclofenac solution (pennsaid) compared with oral diclofenac in symptomatic treatment of osteoarthritis of the knee: a randomized controlled trialJ Rheumatol200431102002201215468367
   PubMed Web of Science ®Google Scholar
• SimonLSGriersonLMNaseerZBookmanAAZev ShainhouseJEfficacy and safety of topical diclofenac containing dimethyl sulfoxide (DMSO) compared with those of topical placebo, DMSO vehicle and oral diclofenac for knee osteoarthritisPain2009143323824519380203
   PubMed Web of Science ®Google Scholar
• BrewerARPierchalaLAYanchickJKMagelliMRovatiSGastrointestinal tolerability of diclofenac epolamine topical patch 1.3%: a pooled analysis of 14 clinical studiesPostgrad Med2011123416817621681001
   PubMed Web of Science ®Google Scholar
• PenistonJHGoldMSWiemanMSAlwineLKLong-term tolerability of topical diclofenac sodium 1% gel for osteoarthritis in seniors and patients with comorbiditiesClin Interv Aging2012751752323204844
   PubMed Web of Science ®Google Scholar
• LinJZhangWJonesADohertyMEfficacy of topical non-steroidal anti-inflammatory drugs in the treatment of osteoarthritis: meta-analysis of randomised controlled trialsBMJ2004329746132415286056
   PubMed Web of Science ®Google Scholar
• RotherMLavinsBJKneerWLehnhardtKSeidelEJMazgareanuSEfficacy and safety of epicutaneous ketoprofen in Transfersome (IDEA-033) versus oral celecoxib and placebo in osteoarthritis of the knee: multicentre randomised controlled trialAnn Rheum Dis20076691178118317363401
   PubMed Web of Science ®Google Scholar
• Zipsor^® (diclofenac potassium) [package insert]Newport, KYXanodyne Pharmaceuticals, Inc2009
   Google Scholar
• DanielsSEBaumDRClarkFGolfMHMcDonnellMEBoesingSEDiclofenac potassium liquid-filled soft gelatin capsules for the treatment of postbunionectomy painCurr Med Res Opin201026102375238420804444
   PubMed Web of Science ®Google Scholar
• HershEVLevinLMAdamsonDDose-ranging analgesic study of Prosorb diclofenac potassium in postsurgical dental painClin Ther20042681215122715476903
   PubMed Web of Science ®Google Scholar
• KowalskiMStokerDGBonCMooreKABoesingSEA pharmacokinetic analysis of diclofenac potassium soft-gelatin capsule in patients after bunionectomyAm J Ther201017546046819531931
   PubMed Web of Science ®Google Scholar
• BelloAEDUEXIS(®) (ibuprofen 800 mg, famotidine 26.6 mg): a new approach to gastroprotection for patients with chronic pain and inflammation who require treatment with a nonsteroidal anti-inflammatory drugTher Adv Musculoskelet Dis20124532733923024710
   PubMedGoogle Scholar
• Zorvolex Highlights of Prescribing Information Available from: https://www.zorvolex.com/wp-content/uploads/2013/12/Zorvolex_Approved_PI.pdfAccessed August 29, 2014
   Google Scholar
• YoungCLStrandVAltmanRDanielsSA phase 2 study of naproxen submicron particle capsules in patients with post-surgical dental painAdv Ther2013301088589624127200
   PubMed Web of Science ®Google Scholar
• CzinnSJHelicobacter pylori infection: detection, investigation, and managementJ Pediatr2005146Suppl 3S21S2615758899
   PubMed Web of Science ®Google Scholar
• VergaraMCatalánMGisbertJPCalvetXMeta-analysis: role of Helicobacter pylori eradication in the prevention of peptic ulcer in NSAID usersAliment Pharmacol Ther200521121411141815948807
   PubMed Web of Science ®Google Scholar
• ManheimerELindeKLaoLBouterLMBermanBMMeta-analysis: acupuncture for osteoarthritis of the kneeAnn Intern Med20071461286887717577006
   PubMed Web of Science ®Google Scholar
• KwonYDPittlerMHErnstEAcupuncture for peripheral joint osteoarthritis: a systematic review and meta-analysisRheumatology (Oxford)200645111331133716936326
   PubMed Web of Science ®Google Scholar
• ManheimerEChengKLindeKAcupuncture for peripheral joint osteoarthritisCochrane Database Syst Rev20101CD00197720091527
   PubMed Web of Science ®Google Scholar
• ThomasKSMuirKRDohertyMJonesACO’ReillySCBasseyEJHome based exercise programme for knee pain and knee osteoarthritis: randomised controlled trialBMJ2002325736775212364304
   PubMed Web of Science ®Google Scholar
• DeyleGDHendersonNEMatekelRLRyderMGGarberMBAllisonSCEffectiveness of manual physical therapy and exercise in osteoarthritis of the knee. A randomized, controlled trialAnn Intern Med2000132317318110651597
   PubMed Web of Science ®Google Scholar
• DeyleGDAllisonSCMatekelRLPhysical therapy treatment effectiveness for osteoarthritis of the knee: a randomized comparison of supervised clinical exercise and manual therapy procedures versus a home exercise programPhys Ther200585121301131716305269
   PubMed Web of Science ®Google Scholar
• FransenMMcConnellSLand-based exercise for osteoarthritis of the knee: a metaanalysis of randomized controlled trialsJ Rheumatol20093661109111719447940
   PubMed Web of Science ®Google Scholar
• ScheimanJMThe use of proton pump inhibitors in treating and preventing NSAID-induced mucosal damageArthritis Res Ther201315Suppl 3S524267413
   PubMed Web of Science ®Google Scholar
• [No authors listed]Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. American College of Rheumatology Subcommittee on Osteoarthritis GuidelinesArthritis Rheum20004391905191511014340
   PubMed Web of Science ®Google Scholar
• RahmeEJosephLKongSXWatsonDJLeLorierJCost of prescribed NSAID-related gastrointestinal adverse events in elderly patientsBr J Clin Pharmacol200152218519211488776
   PubMed Web of Science ®Google Scholar
• LatimerNLordJGrantRLO’MahonyRDicksonJConaghanPGNational Institute for Health and Clinical Excellence Osteoarthritis Guideline Development GroupCost effectiveness of COX 2 selective inhibitors and traditional NSAIDs alone or in combination with a proton pump inhibitor for people with osteoarthritisBMJ2009339b253819602530
   PubMed Web of Science ®Google Scholar